The Board of Directors of Tata Steel Limited met on March 17, 2026, approving three key proposals. These include the amalgamation of its wholly-owned subsidiary, Neelachal Ispat Nigam Limited (NINL), into Tata Steel. Furthermore, the Board sanctioned an investment of up to USD 2 Billion in its foreign subsidiary, T Steel Holdings Pte. Ltd., and the acquisition of the remaining stake in Medica TS Hospital Private Limited to make it a wholly-owned subsidiary.
Key Decisions from March 17, 2026 Board Meeting
Tata Steel Limited’s Board of Directors convened on Tuesday, March 17, 2026, concluding its meeting at 5:15 p.m. (IST). The Board approved three significant corporate actions aimed at streamlining operations, improving efficiency, and strengthening healthcare access.
1. Amalgamation with Neelachal Ispat Nigam Limited (NINL)
The primary approval was for the Scheme of Amalgamation involving Neelachal Ispat Nigam Limited (NINL), a wholly-owned subsidiary, and Tata Steel (the Transferee Company). The amalgamation is designed to create significant synergies, simplify the group structure, and eliminate administrative duplication. Financial data as of March 31, 2025, showed NINL’s standalone revenue from operations at ₹5,701.06 crore.
Synergies and Rationale
The scheme targets several operational benefits, including:
- Simplified Structure and Management Efficiency: Eliminating duplicate administrative costs.
- Operational Integration: Reducing order management costs and improving sales planning.
- Improved Raw Material Security: Centralizing the use of iron ore sourced from mines owned by both entities.
- Centralized Procurement: Improving negotiating power through centralized inventory management.
Upon effect, the entire paid-up share capital of NINL will stand cancelled. Tata Steel’s shareholding percentage in itself will remain unchanged post-arrangement at 33.19% for the Promoter & Promoter Group.
2. Investment in Overseas Subsidiary
The Board approved an investment of funds up to USD 2 Billion (approximately ₹18,488.10 crore, based on the exchange rate of ₹92.4405 per USD) into T Steel Holdings Pte. Ltd. (TSHP), the company’s wholly-owned foreign subsidiary based in Singapore.
This capital infusion will be deployed in one or more tranches starting from FY2026-27. The funds are intended to support overseas subsidiaries for business operations, capital expenditure, restructuring costs, and the repayment/prepayment of existing debt. TSHP is categorized as an Investment Holding Company.
3. Acquisition of Remaining Stake in Medica TS Hospital
Tata Steel will acquire the remaining securities in Medica TS Hospital Private Limited for an aggregate consideration of ₹1.49 crore. This transaction will result in Medica TS Hospital becoming a wholly owned subsidiary of Tata Steel Limited post-completion.
The acquisition involves:
- 7,40,000 equity shares, constituting the remaining 49% equity stake.
- 2,30,05,182 Optionally Convertible Redeemable Preference Shares, constituting 31.85% of preference share stake.
The rationale is to strengthen access to healthcare for Tata Steel’s employees and the local community, as the hospital is the only multi-speciality facility in Kalinganagar. The acquisition is expected to complete within 1 month.
Pre-acquisition, Tata Steel held 51.00% of equity, which will increase to 100.00% post-acquisition, as detailed in Annexure 4.
Source: BSE
